213 related articles for article (PubMed ID: 8928236)
1. [CD34+ cells: biological aspects].
Benedetti F
Tumori; 1996; 82(2 Suppl):S3-13. PubMed ID: 8928236
[TBL] [Abstract][Full Text] [Related]
2. Concomitant mobilization of plasma cells and hematopoietic progenitors into peripheral blood of patients with multiple myeloma.
Lemoli RM; Cavo M; Fortuna A
J Hematother; 1996 Aug; 5(4):339-49. PubMed ID: 8877709
[TBL] [Abstract][Full Text] [Related]
3. CD34+ subset and tumor cell quantitation by flow cytometry--step toward quality assessment of autografts in B cell malignancies.
Johnsen HE; Rasmussen T; Knudsen LM
Vox Sang; 1998; 74 Suppl 2():477-82. PubMed ID: 9704485
[TBL] [Abstract][Full Text] [Related]
4. Rapid engraftment after allogeneic transplantation of density-enriched peripheral blood CD34+ cells in patients with advanced hematologic malignancies.
Cao TM; Kusnierz-Glaz C; Valone F; Stockerl-Goldstein KE; Hu WW; Johnston L; Blume KG; Strober S; Negrin RS
Cancer; 2001 Jun; 91(12):2205-13. PubMed ID: 11413507
[TBL] [Abstract][Full Text] [Related]
5. Allogeneic transplantation of positively selected peripheral blood CD34+ progenitor cells from matched related donors.
Finke J; Brugger W; Bertz H; Behringer D; Kunzmann R; Weber-Nordt RM; Kanz L; Mertelsmann R
Bone Marrow Transplant; 1996 Dec; 18(6):1081-6. PubMed ID: 8971376
[TBL] [Abstract][Full Text] [Related]
6. The role of granulocyte colony-stimulating factor in mobilization and transplantation of peripheral blood progenitor and stem cells .
Haas R; Murea S
Cytokines Mol Ther; 1995 Dec; 1(4):249-70. PubMed ID: 9384679
[TBL] [Abstract][Full Text] [Related]
7. Elimination of bcl-2-IgH-positive follicular lymphoma cells from blood transplants with high recovery of hematopoietic progenitors by the miltenyi CD34+ cell sorting system.
Di Nicola M; Siena S; Corradini P; Bregni M; Milanesi M; Magni M; Ruffini PA; Ravagnani F; Tarella C; Gianni AM
Bone Marrow Transplant; 1996 Dec; 18(6):1117-21. PubMed ID: 8971381
[TBL] [Abstract][Full Text] [Related]
8. Isolation of purified autologous peripheral blood CD34+ cells with low T cell content using CliniMACS device--a local experience.
Leong CF; Habsah A; Teh HS; Goh KY; Fadilah SA; Cheong SK
Malays J Pathol; 2008 Jun; 30(1):31-6. PubMed ID: 19108409
[TBL] [Abstract][Full Text] [Related]
9. Stem cell function and engraftment is not affected by "in vivo purging" with rituximab for autologous stem cell treatment for patients with low-grade non-Hodgkin's lymphoma.
Buckstein R; Imrie K; Spaner D; Potichnyj A; Robinson JB; Nanji S; Pennel N; Reis M; Pinkerton P; Dubé I; Hewitt K; Berinstein NL
Semin Oncol; 1999 Oct; 26(5 Suppl 14):115-22. PubMed ID: 10561026
[TBL] [Abstract][Full Text] [Related]
10. Positive selection of autologous peripheral blood stem cells.
Lopez M; Beaujean F
Baillieres Best Pract Res Clin Haematol; 1999; 12(1-2):71-86. PubMed ID: 11000984
[TBL] [Abstract][Full Text] [Related]
11. Autologous and allogeneic transplantation with peripheral blood CD34+ cells: a pediatric experience.
Watanabe T; Kawano Y; Watanabe A; Takaue Y
Haematologica; 1999 Feb; 84(2):167-76. PubMed ID: 10091416
[TBL] [Abstract][Full Text] [Related]
12. Successful collection and transplantation of peripheral blood stem cells in cancer patients using large-volume leukaphereses.
Murea S; Goldschmidt H; Hahn U; Pförsich M; Moos M; Haas R
J Clin Apher; 1996; 11(4):185-94. PubMed ID: 8986864
[TBL] [Abstract][Full Text] [Related]
13. Autografting with peripheral blood stem cells mobilized by sequential interleukin-3/granulocyte-macrophage colony-stimulating factor following high-dose chemotherapy in non-Hodgkin's lymphoma.
Haas R; Ehrhardt R; Witt B; Goldschmidt H; Hohaus S; Pförsich M; Ehrlich H; Färber L; Hunstein W
Bone Marrow Transplant; 1993 Dec; 12(6):643-9. PubMed ID: 7511017
[TBL] [Abstract][Full Text] [Related]
14. The CD34 hemopoietic progenitor cell associated antigen: biology and clinical applications.
Silvestri F; Banavali S; Baccarani M; Preisler HD
Haematologica; 1992; 77(3):265-73. PubMed ID: 1385274
[TBL] [Abstract][Full Text] [Related]
15. CXCR-4 expression on bone marrow CD34+ cells prior to mobilization can predict mobilization adequacy in patients with hematologic malignancies.
Dabusti M; Lanza F; Campioni D; Castagnari B; Tieghi A; Moretti S; Punturieri M; De Angeli C; Spanedda R; Ferrazzi E; Castoldi G
J Hematother Stem Cell Res; 2003 Aug; 12(4):425-34. PubMed ID: 12965079
[TBL] [Abstract][Full Text] [Related]
16. Autografting of highly purified peripheral blood progenitor cells following myeloablative therapy in patients with lymphoma: a prospective study of the long-term effects on tumor eradication, reconstitution of hematopoiesis and immune recovery.
Dreger P; Viehmann K; von Neuhoff N; Glaubitz T; Petzoldt O; Glass B; Uharek L; Rautenberg P; Suttorp M; Mills B; Mitsky P; Schmitz N
Bone Marrow Transplant; 1999 Jul; 24(2):153-61. PubMed ID: 10455343
[TBL] [Abstract][Full Text] [Related]
17. Immunocytochemical detection of breast cancer cells in marrow and peripheral blood of patients undergoing high dose chemotherapy with autologous stem cell support.
Franklin WA; Shpall EJ; Archer P; Johnston CS; Garza-Williams S; Hami L; Bitter MA; Bast RC; Jones RB
Breast Cancer Res Treat; 1996; 41(1):1-13. PubMed ID: 8932871
[TBL] [Abstract][Full Text] [Related]
18. Factors that influence the collection and engraftment of allogeneic peripheral-blood stem cells in patients with hematologic malignancies.
Brown RA; Adkins D; Goodnough LT; Haug JS; Todd G; Wehde M; Hendricks D; Ehlenbeck C; Laub L; DiPersio J
J Clin Oncol; 1997 Sep; 15(9):3067-74. PubMed ID: 9294469
[TBL] [Abstract][Full Text] [Related]
19. Ex vivo expansion of megakaryocyte progenitors: effect of various growth factor combinations on CD34+ progenitor cells from bone marrow and G-CSF-mobilized peripheral blood.
Gehling UM; Ryder JW; Hogan CJ; Hami L; McNiece I; Franklin W; Williams S; Helm K; King J; Shpall EJ
Exp Hematol; 1997 Oct; 25(11):1125-39. PubMed ID: 9328449
[TBL] [Abstract][Full Text] [Related]
20. Successful autografting following myeloablative conditioning therapy with blood stem cells mobilized by chemotherapy plus rhG-CSF.
Hohaus S; Goldschmidt H; Ehrhardt R; Haas R
Exp Hematol; 1993 Apr; 21(4):508-14. PubMed ID: 7681782
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
